Abivax (ABVX) DMA 200 (2024 - 2026)

Abivax (ABVX) DMA 200 (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	DMA 200
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	3.91
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	135.28
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	8.38
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	25.77
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	16.79
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	4.44
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	9.96
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	437.41
9	Abivax	94.37 Bn	94.37 Bn	-	110.18
10	Regeneron Pharmaceuticals	63.60 Bn	54.85 Bn	3.31 Bn	695.99

Download Data